NCT05450276View on ClinicalTrials.gov

Patient-Reported Outcome Study of Project ECHO for ILD

UnknownOBSERVATIONAL

Enrollment

56

Participants

Timeline

Start Date

July 31, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

March 31, 2024

Conditions

Interstitial Lung Disease

Trial Locations (1)

02130

Pulmonary Care and Research Collaborative, Ltd., Boston

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Pulmonary Care and Research Collaborative Limited

OTHER

NCT05450276 - Patient-Reported Outcome Study of Project ECHO for ILD | Biotech Hunter | Biotech Hunter